Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro

This publication has 34 references indexed in Scilit:

• Phosphorylation of Bcl-2 Protein by CDC2 Kinase during G2/M Phases and Its Role in Cell Cycle Regulation
  Published by Elsevier ,2000
• Computerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth: a Rational Approach to Clinical Protocol Design
  JNCI Journal of the National Cancer Institute, 1994
• Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1993
• Long-term neuropsychologic sequelae of childhood leukemia: Comparison of two CNS prophylactic regimens
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Effects of CPT‐11 in combination with other anti‐cancer agents in culture
  International Journal of Cancer, 1992
• Increase in topoisomerase‐II‐mediated dna breaks and cytotoxicity of VP16 in human U937 lymphoma cells pretreated with low doses of methotrexate
  International Journal of Cancer, 1990
• Synergistic effect of methotrexate and 1-β-d-arabinofuranosylcytosine on the generation of DNA strand breaks in a human promyelocytic leukemia cell line
  Leukemia Research, 1988
• Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.
  Journal of Clinical Investigation, 1979
• Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210
  Published by Elsevier ,1974
• Combination chemotherapy: The antagonism of methotrexate and cytosine arabinoside
  Published by Elsevier ,1973